SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Qiao Liu · Study

Home/Author

Qiao Liu

2 works· latest 2021· 1 institutionscluster: provisionalORCID 0000-0001-8739-6236

h-index2

i102

Citations103

Works here2

19

21

Most cited in this library

Cost-Effectiveness of Domestic PD-1 Inhibitor Camrelizumab Combined With Chemotherapy in the First-Line Treatment of Advanced Nonsquamous Non–Small-Cell Lung Cancer in China2021 · 55 citations
Nivolumab Versus Docetaxel for Previously Treated Advanced Non-Small Cell Lung Cancer in China: A Cost-Effectiveness Analysis2019 · 48 citations

Works

2 shown

Cost-Effectiveness of Domestic PD-1 Inhibitor Camrelizumab Combined With Chemotherapy in the First-Line Treatment of Advanced Nonsquamous Non–Small-Cell Lung Cancer in China

Frontiers in Pharmacology·2021·4 authors·Open access

55citations

Nivolumab Versus Docetaxel for Previously Treated Advanced Non-Small Cell Lung Cancer in China: A Cost-Effectiveness Analysis

Clinical Drug Investigation·2019·7 authors·Open access

48citations